首页> 外文期刊>International journal of hematology >Langerhans cell histiocytosis with multifocal bone lesions: comparative clinical features between single and multi-systems.
【24h】

Langerhans cell histiocytosis with multifocal bone lesions: comparative clinical features between single and multi-systems.

机译:郎格罕氏细胞组织细胞增生症伴多灶性骨病变:单系统和多系统之间的比较临床特征。

获取原文
获取原文并翻译 | 示例
           

摘要

Langerhans cell histiocytosis (LCH) can be a single system or multi-system disease. Both disease types can be associated with multi-focal bone lesions, but their bone involvement patterns have not been compared systematically. Of the new pediatric LCH cases enrolled into the JLSG-02 study during 2002-2007, 67 cases of single system multifocal bone (SMFB) LCH and 97 cases of multi-system bone (MSB) LCH were analyzed to determine if the bone involvement patterns differ in these two types, and whether these differences correlate with outcome. Statistical analysis was performed with Mann-Whitney U test, Fisher's exact test, and other measures. Onset ages were higher for SMFB (P < 0.001), but the two types did not differ in the number of bone lesions per patient. The skull was most frequently affected in both types, followed by the spine. Lesions in the temporal bone (P = 0.002), ear-petrous bone (P < 0.001), orbita (P = 0.003), and zygomatic bone (P = 0.016) were significantly more common in MSB. The two types did not differ in response to treatment, but MSB was associated with a significantly higher incidence of diabetes insipidus (DI) (P < 0.001). Novel measures are required in preventing the development of DI in MSB-type LCH patients with "risk" bone lesions.
机译:朗格汉斯细胞组织细胞增生症(LCH)可以是单系统疾病,也可以是多系统疾病。两种疾病类型均可与多灶性骨病变相关,但尚未系统比较它们的骨受累模式。在2002-2007年纳入JLSG-02研究的新的小儿LCH病例中,分析了67例单系统多焦点骨(SMFB)LCH和97例多系统骨(MSB)LCH,以确定是否有骨受累类型两种类型的差异以及这些差异是否与结果相关。使用Mann-Whitney U检验,Fisher精确检验和其他措施进行统计分析。 SMFB的发病年龄较高(P <0.001),但两种类型的每例患者的骨病变数量没有差异。两种类型的颅骨最常见,其次是脊椎。在MSB中,颞骨(P = 0.002),耳骨(P <0.001),眼眶(P = 0.003)和骨(P = 0.016)病变明显得多。两种类型对治疗的反应无差异,但MSB与尿崩症(DI)的发生率显着相关(P <0.001)。需要采取新的措施来防止MSB型LCH患者的“危险”骨病变发生DI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号